Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Drug Delivery
  4. Fast Track Articles
  5. Fast Track Article
image of Local Delivery of Ginger Extract via a Nanofibrous Membrane Suppresses Human Skin Melanoma B16F10 Cells Growth via Targeting Ras/ERK and PI3K/AKT Signaling Pathways: An In vitro Study

Abstract

Background

Metastatic melanoma poses a significant threat globally, with a distressingly low ten-year survival rate of only 10%. While FDA-approved treatments such as dacarbazine and high-dose IL-2 have been employed in clinical settings, their limitations underscore the urgent need for more effective therapies.

Aims

This study aimed to develop a potential anticancer local treatment through the extraction of various amounts of ginger extract loaded unto Poly(vinyl alcohol) (PVA) nanofibers.

Methods

The anticancer activity of the produced membranes was studied on human skin melanoma B16F10 cells. Other experiments such as cell migration assay, cell proliferation assay, cell viability assay, scanning electron microscopy assay, real-time PCR assay, and ant-inflammatory assay were performed for the characterization of the delivery system. Tissue toxicity of the developed patches was studied in a rat model.

Results

The study showed that scaffolds loaded with 2%, 4%, 6%, 8%, and 0% of ginger extract had around 784.98 ± 202.31 nm, 771.86 ± 219.07 nm, 820.65 ± 242.43 nm, 785.19 ± 203.99 nm, and 671.29 ± 184.09 nm of mean fiber size, respectively. The ginger extract-loaded membranes suppressed the growth and migration activity of human skin melanoma B16F10 cells in a dose and time-dependent manner. Real-time PCR assay showed that the developed membranes modulated the expression levels of Ras/ERK and PI3K/AKT signaling pathways. Animal study results showed that our developed patches were not toxic against liver or skin tissues.

Conclusion

Ginger extract-loaded PVA nanofibers exhibited promising anticancer potential against melanoma cells, suggesting a viable localized treatment option.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdd/10.2174/0115672018319584241008075033
2024-10-15
2024-11-23

  • From This Site

    /content/journals/cdd/10.2174/0115672018319584241008075033
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Vandyck H.H.L.D. Hillen L.M. Bosisio F.M. van den Oord J. zur Hausen A. Winnepenninckx V. Rethinking the biology of metastatic melanoma: A holistic approach. Cancer Metastasis Rev. 2021 40 2 603 624 10.1007/s10555‑021‑09960‑8 33870460
    [Google Scholar]
  2. Bjørch M.F. Gram E.G. Brodersen J.B. Overdiagnosis in malignant melanoma: A scoping review. BMJ Evid. Based Med. 2024 29 1 17 28 10.1136/bmjebm‑2023‑112341 37793786
    [Google Scholar]
  3. Tønder J.E. Bønnelykke-Behrndtz M.L. Laurberg T. Røssell E.L. Sollie M. Melanoma risk, tumour stage, and melanoma-specific mortality in individuals with diabetes: a systematic review and meta-analysis. BMC Cancer 2024 24 1 812 10.1186/s12885‑024‑12598‑8 38972968
    [Google Scholar]
  4. de Bree E. Complications of Surgery for Cutaneous Melanoma. Side Effects of Cancer Therapy Springer: Cham 2024 10.1007/978‑3‑030‑93702‑7_36‑1
    [Google Scholar]
  5. Caraban B.M. Aschie M. Deacu M. Cozaru G.C. Pundiche M.B. Orasanu C.I. Voda R.I. A Narrative Review of Current Knowledge on Cutaneous Melanoma. Clin. Pract. 2024 14 1 214 241 10.3390/clinpract14010018 38391404
    [Google Scholar]
  6. Kuryk L. Bertinato L. Staniszewska M. Pancer K. Wieczorek M. Salmaso S. Caliceti P. Garofalo M. From conventional therapies to immunotherapy: melanoma treatment in review. Cancers (Basel) 2020 12 10 3057 10.3390/cancers12103057 33092131
    [Google Scholar]
  7. Patel H. Yacoub N. Mishra R. White A. Yuan L. Alanazi S. Garrett J.T. Current advances in the treatment of BRAF-mutant melanoma. Cancers (Basel) 2020 12 2 482 10.3390/cancers12020482 32092958
    [Google Scholar]
  8. Switzer B. Puzanov I. Skitzki J.J. Hamad L. Ernstoff M.S. Managing metastatic melanoma in 2022: a clinical review. JCO Oncol. Pract. 2022 18 5 335 351 10.1200/OP.21.00686 35133862
    [Google Scholar]
  9. Robertson B.M. Determinants of resistance and response to melanoma therapy. Nat Cancer. 2024 5 7 964 982
    [Google Scholar]
  10. Natarelli N. Aleman S.J. Mark I.M. Tran J.T. Kwak S. Botto E. Aflatooni S. Diaz M.J. Lipner S.R. A review of current and pipeline drugs for treatment of melanoma. Pharmaceuticals (Basel) 2024 17 2 214 10.3390/ph17020214 38399429
    [Google Scholar]
  11. Routy B. Jackson T. Mählmann L. Baumgartner C.K. Blaser M. Byrd A. Corvaia N. Couts K. Davar D. Derosa L. Hang H.C. Hospers G. Isaksen M. Kroemer G. Malard F. McCoy K.D. Meisel M. Pal S. Ronai Z. Segal E. Sepich-Poore G.D. Shaikh F. Sweis R.F. Trinchieri G. van den Brink M. Weersma R.K. Whiteson K. Zhao L. McQuade J. Zarour H. Zitvogel L. Melanoma and microbiota: Current understanding and future directions. Cancer Cell 2024 42 1 16 34 10.1016/j.ccell.2023.12.003 38157864
    [Google Scholar]
  12. Viegas J. Sarmento B. Bridging the gap between testing and clinics exploring alternative pre-clinical models in melanoma research. Adv. Drug Deliv. Rev. 2024 208 115295 10.1016/j.addr.2024.115295 38527625
    [Google Scholar]
  13. Kowalski S. Karska J. Tota M. Skinderowicz K. Kulbacka J. Drąg-Zalesińska M. Natural Compounds in Non-Melanoma Skin Cancer: Prevention and Treatment. Molecules 2024 29 3 728 10.3390/molecules29030728 38338469
    [Google Scholar]
  14. Imtiaz I. Schloss J. Bugarcic A. Traditional and contemporary herbal medicines in management of cancer: A scoping review. J. Ayurveda Integr. Med. 2024 15 1 100904 10.1016/j.jaim.2024.100904 38395014
    [Google Scholar]
  15. Bakr A.F. Ginger extract and ginger nanoparticles; Characterization and applications. J. Vet. Sci. 2020 9 2 203 209
    [Google Scholar]
  16. Kamaruddin M.S.H. Chong G.H. Mohd Daud N. Putra N.R. Md Salleh L. Suleiman N. Bioactivities and green advanced extraction technologies of ginger oleoresin extracts: A review. Food Res. Int. 2023 164 112283 10.1016/j.foodres.2022.112283 36737895
    [Google Scholar]
  17. Garza-Cadena C. Ortega-Rivera D.M. Machorro-García G. Gonzalez-Zermeño E.M. Homma-Dueñas D. Plata-Gryl M. Castro-Muñoz R. A comprehensive review on Ginger (Zingiber officinale) as a potential source of nutraceuticals for food formulations: Towards the polishing of gingerol and other present biomolecules. Food Chem. 2023 413 135629 10.1016/j.foodchem.2023.135629 36753787
    [Google Scholar]
  18. Kiyama R. Nutritional implications of ginger: chemistry, biological activities and signaling pathways. J. Nutr. Biochem. 2020 86 108486 10.1016/j.jnutbio.2020.108486 32827666
    [Google Scholar]
  19. Nutakor C. Essiedu J.A. Adadi P. Kanwugu O.N. Ginger beer: An overview of health benefits and recent developments. Fermentation (Basel) 2020 6 4 102 10.3390/fermentation6040102
    [Google Scholar]
  20. Osman A.M.E. In-vitro anticancer and cytotoxic activity of ginger extract on human breast cell lines. Khartoum Journal of Pharmaceutical Sciences 2020 1 1 26 29
    [Google Scholar]
  21. Cojocaru S.I. Stan M. Stoian G. Dinischiotu A. Effects of zingiber officinale roscoe fresh extract on amelanotic melanoma and normal skin fibroblasts. Rev. Med. Chir. Soc. Med. Nat. Iasi 2015 119 2 592 596 26204672
    [Google Scholar]
  22. Adikesavan M. Athiraja P. Divakar M.B.B. Investigation on the Anticancer Activity of [6]-Gingerol of Zingiber officinale and its Structural Analogs against Skin Cancer. Curr. Computeraided Drug Des. 2024 20 4 367 373 10.2174/1573409919666230418095105 37076965
    [Google Scholar]
  23. Luraghi A. Peri F. Moroni L. Electrospinning for drug delivery applications: A review. J. Control. Release 2021 334 463 484 10.1016/j.jconrel.2021.03.033 33781809
    [Google Scholar]
  24. Zahra F.T. Quick Q. Mu R. Electrospun PVA fibers for drug delivery: A review. Polymers (Basel) 2023 15 18 3837 10.3390/polym15183837 37765691
    [Google Scholar]
  25. Rivera-Hernández G. Antunes-Ricardo M. Martínez-Morales P. Sánchez M.L. Polyvinyl alcohol based-drug delivery systems for cancer treatment. Int. J. Pharm. 2021 600 120478 10.1016/j.ijpharm.2021.120478 33722756
    [Google Scholar]
  26. Abdelbasset W.K. Elkholi S.M. Ismail K.A. AL-Ghamdi H.S. Mironov S. Ridha H.S.H. Maashi M.S. Thangavelu L. Mahmudiono T. Mustafa Y.F. Mequinol-loaded carboxymethyl cellulose/chitosan electrospun wound dressing as a potential candidate to treat diabetic wounds. Cellulose 2022 29 14 7863 7881 10.1007/s10570‑022‑04753‑w
    [Google Scholar]
  27. Žitek T. Bjelić D. Kotnik P. Golle A. Jurgec S. Potočnik U. Knez Ž. Finšgar M. Krajnc I. Krajnc I. Marevci M.K. Natural Hemp-Ginger Extract and Its Biological and Therapeutic Efficacy. Molecules 2022 27 22 7694 10.3390/molecules27227694 36431795
    [Google Scholar]
  28. Weng C.J. Wu C.F. Huang H.W. Ho C.T. Yen G.C. Anti‐invasion effects of 6‐shogaol and 6‐gingerol, two active components in ginger, on human hepatocarcinoma cells. Mol. Nutr. Food Res. 2010 54 11 1618 1627 10.1002/mnfr.201000108 20521273
    [Google Scholar]
  29. Wang L.X. Qian J. Zhao L.N. Zhao S.H. Effects of volatile oil from ginger on the murine B16 melanoma cells and its mechanism. Food Funct. 2018 9 2 1058 1069 10.1039/C7FO01127J 29355275
    [Google Scholar]
  30. Lechner J.F. Stoner G.D. Gingers and their purified components as cancer chemopreventative agents. Molecules 2019 24 16 2859 10.3390/molecules24162859 31394732
    [Google Scholar]
  31. Kaewtunjai N. Wongpoomchai R. Imsumran A. Pompimon W. Athipornchai A. Suksamrarn A. Lee T.R. Tuntiwechapikul W. Ginger extract promotes telomere shortening and cellular senescence in A549 lung cancer cells. ACS Omega 2018 3 12 18572 18581 10.1021/acsomega.8b02853 32010796
    [Google Scholar]
  32. Huang H.C. Chiu S.H. Chang T.M. Inhibitory effect of [6]-gingerol on melanogenesis in B16F10 melanoma cells and a possible mechanism of action. Biosci. Biotechnol. Biochem. 2011 75 6 1067 1072 10.1271/bbb.100851 21670536
    [Google Scholar]
  33. Yusof Y.A. Ahmad N. Das S. Sulaiman S. Murad N.A. Chemopreventive efficacy of ginger (Zingiber officinale) in ethionine induced rat hepatocarcinogenesis. Afr. J. Tradit. Complement. Altern. Med. 2008 6 1 87 93 20162046
    [Google Scholar]
  34. Stoilova I. Krastanov A. Stoyanova A. Denev P. Gargova S. Antioxidant activity of a ginger extract (Zingiber officinale). Food Chem. 2007 102 3 764 770 10.1016/j.foodchem.2006.06.023
    [Google Scholar]
  35. Si W. Chen Y.P. Zhang J. Chen Z.Y. Chung H.Y. Antioxidant activities of ginger extract and its constituents toward lipids. Food Chem. 2018 239 1117 1125 10.1016/j.foodchem.2017.07.055 28873530
    [Google Scholar]
  36. An S. Liu G. Guo X. An Y. Wang R. Ginger extract enhances antioxidant ability and immunity of layers. Anim. Nutr. 2019 5 4 407 409 10.1016/j.aninu.2019.05.003 31890918
    [Google Scholar]
  37. Masuda Y. Kikuzaki H. Hisamoto M. Nakatani N. Antioxidant properties of gingerol related compounds from ginger. Biofactors 2004 21 1-4 293 296 10.1002/biof.552210157 15630214
    [Google Scholar]
  38. Neagu M. Constantin C. Caruntu C. Dumitru C. Surcel M. Zurac S. Inflammation: A key process in skin tumorigenesis. Oncol. Lett. 2019 17 5 4068 4084 30944600
    [Google Scholar]
  39. Zhou X. Afzal S. Wohlmuth H. Münch G. Leach D. Low M. Li C.G. Synergistic Anti-Inflammatory Activity of Ginger and Turmeric Extracts in Inhibiting Lipopolysaccharide and Interferon-γ-Induced Proinflammatory Mediators. Molecules 2022 27 12 3877 10.3390/molecules27123877 35745000
    [Google Scholar]
  40. Pappalardo F. Russo G. Candido S. Pennisi M. Cavalieri S. Motta S. McCubrey J.A. Nicoletti F. Libra M. Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer. PLoS One 2016 11 3 e0152104 10.1371/journal.pone.0152104 27015094
    [Google Scholar]
  41. Calori I.R. Braga G. de Jesus P.C.C. Bi H. Tedesco A.C. Polymer scaffolds as drug delivery systems. Eur. Polym. J. 2020 129 109621 10.1016/j.eurpolymj.2020.109621
    [Google Scholar]
  42. Ebadi M. Bullo S. Buskara K. Hussein M.Z. Fakurazi S. Pastorin G. Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications. Sci. Rep. 2020 10 1 21521 10.1038/s41598‑020‑76504‑5 33298980
    [Google Scholar]
  43. Rondanelli M. Fossari F. Vecchio V. Gasparri C. Peroni G. Spadaccini D. Riva A. Petrangolini G. Iannello G. Nichetti M. Infantino V. Perna S. Clinical trials on pain lowering effect of ginger: A narrative review. Phytother. Res. 2020 34 11 2843 2856 10.1002/ptr.6730 32436242
    [Google Scholar]
/content/journals/cdd/10.2174/0115672018319584241008075033
Loading
Local Delivery of Ginger Extract via a Nanofibrous Membrane Suppresses Human Skin Melanoma B16F10 Cells Growth via Targeting Ras/ERK and PI3K/AKT Signaling Pathways: An In vitro Study
Bentham Science Publishers ; https://doi.org/10.2174/0115672018319584241008075033
/content/journals/cdd/10.2174/0115672018319584241008075033
/content/journals/cdd/10.2174/0115672018319584241008075033
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: Ginger ; drug delivery, anti-cancer, local treatment, melanoma ; nanofibers

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test